Continuous subcutaneous octreotide in gastrointestinal cancer patients: Pain control and β-endorphin levels

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 4039-4046

  Befon, S ^a   Mystakidou, K ^a   Lyra, M ^a   Tubanakis, N ^a   Vlahos, L ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

B endorphin; Continuous subcutaneous; Gastrointestinal cancer; Octreotide; Pain control; Somatostatin

Indexed keywords

ANALGESIC AGENT; BETA ENDORPHIN; MORPHINE; OCTREOTIDE; SOMATOSTATIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD CELL COUNT; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIARRHEA; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; FEMALE; HUMAN; INFUSION PUMP; LIVER FUNCTION; MALE; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; STEATORRHEA; TREATMENT OUTCOME; VOMITING;

AGED; AGED, 80 AND OVER; ANALGESICS; BETA-ENDORPHIN; BIOLOGICAL MARKERS; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL NEOPLASMS; HUMANS; INFUSIONS, PARENTERAL; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OCTREOTIDE; PAIN; PAIN MEASUREMENT; TIME FACTORS;

EID: 0034529381     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
2. Cloning of a novel somatostatin receptor, SSTR 3, coupled to adenylcyclase
3. Characterization of cloned somatostatin receptor, SSTR 4 and SSTR5
4. All five human cloned human somatostatin receptors (hSSTRI-5) are finally coupled to adenylcyclase
5. Phospholipase C activation and Ca mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells
6. Effect of Sandostatin on CRF. stimulated secretion of ACTH, blipotropin and b-endorphin
7. In Vitro autoradiographic and in Vivo scintigraphic localization of somatostatin receptors in human hymphatic tissue
8. The physiology of somatostatin and its synthetic analogue, octreotide
9. Somatostatin a potent analgesic
10. A randomized trial of octreotide Vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy
11. Calcitonin and somatostatin induced analgesia in pain from cancer
12. Octreotide (sandostatin) for treatment of cancer pain
13. Intrathical octreotide for cancer pairi
14. The evolving clinical uses of octreotide
15. Somatostatin: A regulatory peptide of clinical importance
16. Oncological application of somatostatin analogues
17. Somatostatin and Analogues in the treatment of Cancer. A review
18. Effects of gastrin, proglumide, and somatostatin on growth on human colon cancer
19. Somatostatin and adifluoromethylornithine (DFMO) have additive inhibitory effects on growth of human colon carcinoma (HCC) in vivo
20. Inhibition of growth of human pancreatic adenocarcinomas in vivo by somatostatin analogue SMS 201- 995
21. The clinical significance of gastrin receptors in human colon cancers
22. Analgesic effect of a somatostatin analogue (octreotide) in headache associated with pituitary tumors
23. The somatostatin analogue octreotide is effective in relieving musculoskeletal pain associated with carcinoid syndrome
24. Somatostatin for chronic pancreatic pain
25. Somatostatin therapy in patients with severe tibromyalgia: A preliminary report
26. Octreotide: A potent new nonopiate analgesic for intrathecal infusion
27. Subcutaneous Octreotide in the treatment of pain in advanced cancer patients
28. Continuous Subcutaneous administration of high-dose salmon calcitonin in bone metastasis: Pain control and beta-endorphin plasma levels
29. Octreotide (Sandostatin) for treatment of cancer pain
30. A phase II study of octreotide in metastatic advanced prostatic cancer
31. Octreotide: Drug therapy
32. The actions of neuropeptides on dorsal horn neurons in the rat spinal cord slice preparation: An intracellular study
33. Depressant actions of methionine enkephalin and somatostatin in the act dorsal horn neurones activated by noxious stimuli
34. Substance P and somatostatin regulate noradrenergic sympathetic function
35. Pharmacodynamic effects of sandostatin in the gastrointestinal tract
36. Somatostatin analogues suppress the inflammatory reaction in vivo
37. Effect of sandostatin on CRF-stimulated secretion of ACTH, β-lipotropin and β-endorphin